Skip to main content

Table 3 EBVCA, EBNA and EA level in serum of patients and control group

From: Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer

Antibodies level (IgG)

Patients

Controls

p

n

%

n

%

EBVCA

negative

6

5.5

0

0

>0.05

low

24

21.8

14

35.0

high

80

72.7

26

65.0

EBNA

negative

4

3.6

0

0

>0.05

low

23

20.9

12

30.0

high

83

75.5

28

70.0

EA

negative

6

5.5

31

77.5

<0.05*

low

27

24.5

9

22.5

high

77

70.0

0

0

  1. *statistically significant